EMEA news
Roche and Microsoft join forces to improve healthcare in Egypt
Roche and Microsoft have signed a Memorandum of Understanding (MoU) to improve patient healthcare outcomes using artificial intelligence (AI) and cloud technology.
The MoU will be implemented in Egypt with a roadmap to roll out the concept across the Middle East, including Egypt, KSA, UAE, Kuwait, Oman, Bahrain, Qatar, Lebanon, Jordan...
The British medtech company Brainomix has announced that it has closed a series B funding round with a total investment of approximately £16 million.
The previous investors Parkwalk, Boehringer Ingelheim Venture Fund (BIVF) and Oxford University Innovation Fund (OUIF), who are participating again in this round, have been joined by Tencent Holdings.
WHY IT MATTERS
Brainomix recently took the ...
A new harmonised regulation on health technology assessment has been adopted across the EU.
The European Commission welcomed the regulation, a deliverable of the EU Pharmaceutical Strategy, which will apply from January 2025.
Work to implement the new rules will start immediately, including the setting up of the necessary governance structure and preparatory documents to ensure effective...
By
06:13 am
December 16, 2021
The profound impact of COVID-19 has changed the lives of people all over the world.
As social distancing became the new normal, new patterns of behaviour and expectations emerged between patients and physicians.
One outcome of this has been an increase in the use of remote patient monitoring (RPM) technology, which can allow patients to receive treatment without travelling to hospital.
For...
HelloBetter, a German organisation focused on digital therapy courses, has announced the release of a new online programme that is a reimbursable digital health application (DiGA) for German doctors and patients.
The digital therapy course targets type 1 and type 2 diabetics with depressive symptoms.
WHY IT MATTERS
According to HelloBetter founder Dr David Ebert, Professor of Psychology and...
Doctor.One focuses on developing a continuous care platform that connects patients with their regular practitioners on a daily basis, and is a mobile-first approach.
WHY IT MATTERS
The aim of the virtual Doctor.One platform is the daily exchange and personal care of patients by doctors they trust. Doctors can subscribe to the service and better accompany their patients through the illness and...
HypnoVR raises €4.5M to accelerate roll-out of digital therapy
French digital therapeutics firm HypnoVR has raised €4.5 million in Series A funding for its virtual reality-based medical hypnosis solution for pain and anxiety.
The round was led by Theodorus, the Banque des Territoires operating for the French state as part of the Investments for the Future Programme, Akiles and Capital Grand...
A new device in the treatment of glaucoma has been introduced by Opthalmic Sciences. IOPerfect works by using artificial intelligence (AI) in a virtual reality-type headset which allows telediagnosis and remote monitoring.
It can be self-administered, and patients can wear the headset to monitor their IOP (fluid pressure inside the eyes) at home. It is non-invasive and without the need for eye...
Swiss healthtech focused private equity firm, MTIP has announced the closing of its MTIP Fund II at $250 million (€221m) in capital commitments.
The oversubscribed fund, which closed above its target of $225 million (€199m), continues its predecessor fund’s strategy of investing in growing and innovative healthtech companies primarily across Europe.
MTIP Fund II is a designated ‘dark green’ fund...
A freely chosen death without ingesting controlled substances is being legalised in Switzerland, with the introduction of 3D technology from the Netherlands.
As Swissinfo reported this month, the 3D printed coffin passed the national legal review and may be used from 2022 for euthanasia.
WHAT’S THE IMPACT
The 3D printed ‘Sarco’ suicide capsule was developed by Australian company Exit...
